Rachel Offenheim

Dec 1, 2024 | jrheum.org | Rachel Offenheim |Omar F Cruz-Correa |Darshini Ganatra |Dafna D Gladman

Key Indexing Terms: biologics biomarkers psoriasis psoriatic arthritis Psoriasis is an inflammatory skin disease mediated by activation of T lymphocyte and innate immune cells leading to keratinocyte hyperproliferation.1,2 Activated T cells produce tumor necrosis factor-α (TNF-α) and interleukins (IL; IL-23, IL-12, and IL-6).2 Subsequently, keratinocytes cause more inflammation through the release of cytokines and chemokines including chemokine ligand 20 (CCL20), C-X-C motif chemokine ligand...

Sep 24, 2024 | jrheum.org | Rachel Offenheim |Omar F Cruz-Correa |Darshini Ganatra |Dafna D Gladman

Candidate Biomarkers for Response to Treatment in Psoriatic Disease Rachel Offenheim, Omar F. Cruz-Correa, Darshini Ganatra, Dafna D. Gladman The Journal of Rheumatology Sep 2024, jrheum.2024-0396; DOI: 10.3899/jrheum.2024-0396

Aug 24, 2024 | jrheum.org | Omar F Cruz-Correa |Dafna D Gladman |Rachel Offenheim |Darshini Ganatra

Candidate Biomarkers For Response To Treatment In Psoriatic Disease Rachel Offenheim, Omar F. Cruz-Correa, Darshini Ganatra, Dafna D. Gladman The Journal of Rheumatology Sep 2024, jrheum.2024-0396; DOI: 10.3899/jrheum.2024-0396